Press "Enter" to skip to content

Ireland suspends AstraZeneca vaccine

Following the allegations that the Covid-19 vaccine, developed by Oxford University and AstraZeneca in England, caused severe blood clotting in adults, the use of the vaccine has been suspended in 11 countries in total as of today.

Ireland was the last country to suspend the use of the AstraZeneca vaccine on suspicion of causing blood clotting.

Irish Health Minister Stephen Donnelly stated that this decision was taken “for precautionary purposes” due to new information from the National Immunization Committee (NIAC).

Ireland Deputy Chief Medical Officer Dr. Ronan Glynn said in a statement, “It has not been concluded that there is any connection between AstraZeneca’s Covid-19 vaccine and blood clotting. However, the National Immunization Advisory Committee has recommended a temporary halt to the AstraZeneca vaccination program in Ireland,” said Ronan Glynn.


In the statement made by the UK Medicines and Health Products Regulatory Authority (MHRA), it was stated that “he closely examined the reports” regarding the suspension of the vaccine in Ireland, and it was stated that “blood clots can occur naturally, but they are rare to develop with the vaccine”. MHRA also stated that more than 11 million people in the UK have received the AstraZeneca vaccine so far.

In Ireland, it was stated that approximately 20% of all doses given so far were AstraZeneca vaccine and it was administered to more than 110 thousand people.

The World Health Organization (WHO) stated that there was no link between the vaccine and the risk of developing blood clots, and stated that countries should not stop using the vaccine for fear of causing blood clotting.

On the other hand, Austria, Italy, Bulgaria, Romania, Estonia, Lithuania, Luxembourg, Latvia, Norway and Iceland have suspended the use of the AstraZeneca vaccine so far.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *